| Date Filed | Type | Description |
| 05/30/2023 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 317,643 options to buy
@ $3.37, valued at
$1.1M
|
|
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/26/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/21/2021 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 227,518 options to buy
@ $19.03, valued at
$4.3M
|
|
| 03/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2021 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Sold 1,800 shares
@ $31.59, valued at
$56.9k
Sold 1,200 shares
@ $32.43, valued at
$38.9k
Exercised 3,000 options to buy
@ $3.24, valued at
$9.7k
|
|
| 01/27/2021 |
4/A
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Exercised 4,000 shares
@ $3.24, valued at
$13k
|
|
| 01/26/2021 |
4
| Shenouda Maged (CFO) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Exercised 4,000 shares
@ $324, valued at
$1.3M
Sold 1,704 shares
@ $35.41, valued at
$60.3k
Sold 409 shares
@ $36.15, valued at
$14.8k
Sold 1,280 shares
@ $35.27, valued at
$45.1k
Sold 607 shares
@ $35.16, valued at
$21.3k
Exercised 4,000 options to buy
@ $3.24, valued at
$13k
|
|
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/21/2019 |
4
| Shenouda Maged (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Bought 978 shares
@ $23, valued at
$22.5k
|
|
| 07/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2019 |
4
| Shenouda Maged (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Bought 20,000 shares
@ $1.3107, valued at
$26.2k
|
|
| 12/20/2018 |
4
| Shenouda Maged (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 450,000 options to buy
@ $1.15, valued at
$517.5k
|
|
| 07/16/2018 |
4
| Shenouda Maged (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 100,000 options
@ $3.04, valued at
$304k
|
|
| 10/23/2017 |
4
| Shenouda Maged (CFO) has filed a Form 4 on AzurRx BioPharma, Inc.|
Txns:
| Granted 22,500 shares
@ $0 |
|
| 10/23/2017 |
4
| Shenouda Maged (Director) has filed a Form 4 on RELMADA THERAPEUTICS, INC.|
Txns:
| Granted 425,000 options to buy
@ $0.81, valued at
$344.3k
|
|
| 09/27/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/11/2016 |
3
| Shenouda Maged (Director) has filed a Form 3 on AzurRx BioPharma, Inc. |